Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WI › West Allis › NPI 1407801640
Hospital

West Allis Memorial Hospital, INC.

West Allis Memorial Hospital, INC. was paid $23.29M by Medicaid between Jan 2018 and Dec 2024, across 329 billing codes. Its largest line is 96361, Intravenous infusion, hydration; each additional hour — 9.7% of everything it billed.

33Billing provider infoWEST ALLIS MEMORIAL HOSPITAL, INC.
WEST ALLIS, WI 53227
33aNPI1407801640assigned 05/24/2006
28Total paid$23.29M
24GClaims1,085,218
24DCodes billed329
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Wisconsin

Rank by total paid#6 of 60
Median peer was paid$2.90M
This provider vs. median8.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official RICHARDSON, KARA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018134,072$2.96M
2019147,999$3.06M
2020136,456$2.98M
2021186,212$3.62M
2022185,853$3.51M
2023176,996$3.80M
2024incomplete117,630$3.36M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
96361 Intravenous infusion, hydration; each additional hour 9.7% 17,317 14,460 $2.27M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 9.2% 35,665 32,008 $2.15M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 9.2% 36,896 32,328 $2.13M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 5.5% 21,153 18,379 $1.28M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 3.4% 27,476 10,831 $801K
99282 Emergency department visit for the evaluation and management, low to moderate severity 3.0% 10,838 9,741 $700K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.8% 8,030 7,247 $644K
70450 Computed tomography, head or brain; without contrast material 2.7% 8,788 7,895 $627K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 2.4% 5,860 5,234 $556K
80053 Comprehensive metabolic panel 2.2% 33,986 26,080 $516K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 1.9% 13,590 6,348 $442K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.6% 5,261 3,692 $373K
317 more codes
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.5% 6,356 $356K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 1.5% 15,910 $346K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.4% 52,071 $331K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1.4% 5,958 $323K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.4% 4,238 $322K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1.3% 4,105 $312K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1.3% 3,192 $306K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1.3% 8,464 $300K
80047 1.2% 12,754 $288K
58661 1.2% 256 $281K
97530 Therapeutic activities, direct patient contact, each 15 minutes 1.1% 13,814 $265K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.1% 3,261 $253K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1.1% 4,928 $246K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.0% 2,254 $239K
71275 Computed tomographic angiography, chest, with contrast material 1.0% 2,719 $235K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 1,186 $230K
G0378 Hospital observation service, per hour <1% 8,557 $222K
84484 <1% 19,366 $202K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 939 $188K
97161 <1% 5,163 $178K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 4,361 $176K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 3,034 $171K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 4,177 $148K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 4,183 $145K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 4,482 $135K
84702 <1% 8,129 $135K
87086 Culture, bacterial; quantitative colony count, urine <1% 11,693 $132K
97535 Self-care/home management training, each 15 minutes <1% 7,717 $120K
97162 <1% 3,143 $116K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 1,587 $114K
83880 <1% 3,775 $114K
93975 <1% 2,568 $112K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 3,017 $110K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 2,417 $107K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 2,376 $105K
80048 Basic metabolic panel (calcium, ionized) <1% 8,523 $105K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 478 $104K
76642 <1% 2,673 $97K
97116 <1% 5,924 $95K
83690 <1% 16,145 $94K
76830 Ultrasound, transvaginal <1% 2,900 $94K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 3,275 $90K
81025 <1% 9,079 $88K
83735 <1% 15,881 $82K
77067 Screening mammography, bilateral, including computer-aided detection <1% 3,672 $82K
82077 <1% 4,262 $81K
82962 <1% 12,417 $78K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 485 $76K
72125 Computed tomography, cervical spine; without contrast material <1% 2,602 $74K
93356 <1% 657 $71K
93971 <1% 2,311 $71K
97165 <1% 2,392 $67K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 914 $60K
86850 <1% 3,094 $57K
81001 <1% 16,635 $56K
83605 <1% 5,340 $49K
82803 <1% 2,463 $47K
77063 Screening digital breast tomosynthesis, bilateral <1% 3,421 $47K
81003 <1% 9,416 $44K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 19,960 $40K
71046 Radiologic examination, chest; 2 views <1% 3,352 $40K
64483 <1% 309 $40K
86900 <1% 3,860 $39K
87040 <1% 2,787 $37K
93970 <1% 824 $37K
71250 <1% 1,160 $36K
87077 <1% 2,737 $34K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 345 $34K
87210 <1% 4,035 $34K
84145 <1% 1,981 $32K
80143 <1% 2,658 $32K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 339 $31K
84443 Thyroid stimulating hormone (TSH) <1% 2,408 $30K
85379 <1% 3,732 $30K
80076 <1% 3,830 $30K
80179 <1% 2,514 $30K
76801 <1% 2,641 $29K
70486 <1% 874 $28K
84703 <1% 3,213 $28K
J0585 Injection, onabotulinumtoxina, 1 unit <1% 256 $27K
93017 <1% 717 $26K
97597 <1% 824 $24K
99213 Doctor's office visit, returning patient (routine) <1% 383 $23K
97166 <1% 761 $23K
76770 <1% 499 $23K
77066 Tomosynthesis, mammo <1% 1,345 $23K
87186 <1% 3,048 $23K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 296 $23K
85610 <1% 6,883 $22K
64484 <1% 312 $22K
70496 <1% 224 $21K
87070 <1% 1,488 $21K
82565 <1% 1,756 $21K
70498 <1% 253 $21K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 260 $20K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 459 $20K
77062 <1% 1,044 $19K
74018 <1% 1,360 $19K
85730 <1% 3,839 $18K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 30,621 $18K
77065 Tomosynthesis, mammo <1% 1,100 $17K
70551 Magnetic resonance imaging, brain; without contrast material <1% 310 $16K
58558 <1% 43 $16K
85027 <1% 2,657 $15K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 51 $15K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 56 $15K
90715 <1% 702 $15K
10060 <1% 181 $14K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 2,447 $14K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 12,441 $13K
12001 <1% 199 $13K
84112 <1% 154 $12K
71045 Radiologic examination, chest; single view <1% 19,144 $12K
87088 <1% 1,716 $12K
51701 <1% 1,857 $11K
72100 <1% 1,936 $11K
19083 <1% 28 $10K
86901 <1% 3,846 $10K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 3,265 $10K
83036 Hemoglobin; glycosylated (A1C) <1% 1,261 $10K
97035 <1% 787 $9K
73630 <1% 2,404 $9K
73221 <1% 110 $8K
70491 <1% 95 $8K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 788 $8K
84132 <1% 1,477 $7K
96367 <1% 105 $7K
82550 <1% 1,468 $7K
77061 <1% 441 $7K
86140 <1% 1,644 $7K
87641 <1% 130 $6K
73562 <1% 2,353 $6K
82728 <1% 583 $6K
87205 <1% 1,763 $6K
P9016 Red blood cells, leukocytes reduced, each unit <1% 14 $6K
12011 <1% 69 $5K
Q3014 Telehealth originating site facility fee <1% 553 $5K
85014 <1% 2,521 $5K
73030 <1% 1,617 $5K
52287 <1% 38 $5K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 251 $4K
83986 <1% 279 $4K
87075 <1% 629 $4K
83615 <1% 882 $4K
88307 <1% 539 $4K
76536 <1% 99 $4K
99214 Doctor's office visit, returning patient (more involved) <1% 76 $4K
80061 Lipid panel <1% 366 $4K
92523 <1% 33 $4K
87081 <1% 116 $3K
72141 <1% 49 $3K
83037 <1% 370 $3K
73130 <1% 1,497 $3K
82570 <1% 551 $3K
J1756 Injection, iron sucrose, 1 mg <1% 1,679 $3K
51798 <1% 527 $3K
Q0114 Fern test <1% 421 $3K
96112 <1% 13 $3K
82140 <1% 263 $3K
73610 <1% 1,723 $3K
78582 <1% 12 $2K
96375 Therapeutic injection; each additional sequential IV push <1% 14,471 $2K
73502 <1% 499 $2K
82435 <1% 100 $2K
82731 <1% 26 $2K
85652 <1% 949 $2K
0399T <1% 67 $2K
74170 <1% 12 $2K
J7030 Infusion, normal saline solution , 1000 cc <1% 34,426 $2K
74178 <1% 12 $2K
82607 <1% 53 $1K
90686 <1% 34 $1K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 41 $1K
74183 <1% 21 $1K
85461 <1% 138 $1K
73110 <1% 696 $1K
84156 <1% 304 $975.47
51741 <1% 12 $955.81
51729 <1% 14 $870.13
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 4,756 $868.31
97163 <1% 34 $865.47
82271 <1% 29 $852.72
J2469 Injection, palonosetron hcl, 25 mcg <1% 1,449 $829.65
96376 <1% 8,008 $827.47
93976 <1% 23 $814.44
77002 <1% 13 $803.02
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 137 $731.03
84460 <1% 150 $662.06
82330 <1% 61 $600.09
80164 <1% 75 $594.82
84550 <1% 112 $580.01
84450 <1% 113 $520.06
84295 <1% 100 $476.20
94060 <1% 12 $462.22
76870 <1% 27 $452.55
82947 <1% 98 $409.11
84439 <1% 53 $400.94
80320 <1% 771 $391.10
84520 <1% 100 $390.44
73564 <1% 30 $383.09
77080 <1% 27 $375.02
0240U <1% 13 $326.78
A4648 Tissue marker, implantable, any type, each <1% 191 $321.30
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 927 $312.87
36000 <1% 615 $305.02
82746 <1% 32 $293.77
88360 <1% 13 $291.98
J0690 Injection, cefazolin sodium, 500 mg <1% 5,305 $279.70
83550 <1% 43 $274.32
84100 <1% 84 $268.81
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 16,048 $265.75
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 8,750 $253.54
87340 <1% 13 $236.13
83540 <1% 46 $217.17
J7120 Ringers lactate infusion, up to 1000 cc <1% 8,142 $147.18
J2704 Injection, propofol, 10 mg <1% 14,595 $128.55
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography <1% 12 $126.44
94729 <1% 12 $123.94
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg <1% 540 $109.61
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 15,366 $109.51
73590 <1% 150 $98.01
90674 <1% 37 $98.00
80329 <1% 48 $95.59
36415 Collection of venous blood by venipuncture <1% 9,556 $91.90
J1170 Injection, hydromorphone, up to 4 mg <1% 8,660 $83.40
87147 <1% 15 $74.90
85018 <1% 36 $63.09
88304 <1% 535 $58.86
73080 <1% 101 $53.78
71101 <1% 30 $50.82
51784 <1% 14 $47.67
P9612 Catheterization for collection of specimen, single patient, all places of service <1% 899 $43.75
72070 <1% 87 $37.86
C1769 Guide wire <1% 1,528 $33.50
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 1,384 $21.73
C9113 Injection, pantoprazole sodium, per vial <1% 1,885 $20.10
J3010 Injection, fentanyl citrate, 0.1 mg <1% 6,436 $18.98
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 5,983 $18.87
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 6,738 $15.94
J7050 Infusion, normal saline solution, 250 cc <1% 4,541 $13.48
J2270 Injection, morphine sulfate, up to 10 mg <1% 6,608 $12.44
88302 <1% 211 $12.12
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 3,535 $9.81
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 18,479 $7.82
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 6,187 $7.50
J1650 Injection, enoxaparin sodium, 10 mg <1% 5,090 $6.68
J0360 Injection, hydralazine hcl, up to 20 mg <1% 544 $6.60
J1644 Injection, heparin sodium, per 1000 units <1% 5,642 $6.20
J1815 Injection, insulin, per 5 units <1% 6,867 $5.97
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 3,202 $2.49
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 624 $0.02
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 2,238 $0.01
J3475 Injection, magnesium sulfate, per 500 mg 0% 1,731 $0.00
A6403 Gauze, non-impregnated, sterile, pad size more than 16 sq. in. less than or equal to 48 sq. in., without adhesive border, each dressing 0% 419 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 0% 1,594 $0.00
Q9957 Injection, perflutren lipid microspheres, per ml 0% 1,802 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 0% 75 $0.00
A4565 Slings 0% 243 $0.00
J0692 Injection, cefepime hydrochloride, 500 mg 0% 309 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 0% 248 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 281 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 237 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 325 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 947 $0.00
J3370 Injection, vancomycin hcl, 500 mg 0% 1,227 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 136 $0.00
C1758 Catheter, ureteral 0% 171 $0.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 0% 403 $0.00
C1729 Catheter, drainage 0% 18 $0.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 0% 258 $0.00
86923 0% 15 $0.00
29125 0% 42 $0.00
73140 0% 55 $0.00
0202U Oncology (prostate), multianalyte, gene expression profiling 0% 15 $0.00
C1776 Joint device (implantable) 0% 28 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 169 $0.00
36600 0% 44 $0.00
A6212 Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing 0% 60 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 0% 13 $0.00
J2370 Injection, phenylephrine hcl, up to 1 ml 0% 844 $0.00
J1630 Injection, haloperidol, up to 5 mg 0% 1,370 $0.00
J3480 Injection, potassium chloride, per 2 meq 0% 2,710 $0.00
A9585 Injection, gadobutrol, 0.1 ml 0% 1,962 $0.00
J0696 Injection, ceftriaxone sodium, per 250 mg 0% 5,066 $0.00
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml 0% 579 $0.00
36410 0% 21 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 254 $0.00
J2060 Injection, lorazepam, 2 mg 0% 4,296 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 0% 157 $0.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 0% 543 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 0% 462 $0.00
J1940 Injection, furosemide, up to 20 mg 0% 356 $0.00
J1790 Injection, droperidol, up to 5 mg 0% 561 $0.00
J1920 Injection, labetalol hydrochloride, 5 mg 0% 201 $0.00
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 0% 1,077 $0.00
J3411 Injection, thiamine hcl, 100 mg 0% 361 $0.00
J7999 Compounded drug, not otherwise classified 0% 189 $0.00
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose 0% 50 $0.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 0% 353 $0.00
J3590 Unclassified biologics 0% 406 $0.00
94644 0% 18 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 0% 106 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 0% 176 $0.00
G8988 Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 97 $0.00
88342 0% 118 $0.00
A9567 Technetium tc-99m pentetate, diagnostic, aerosol, per study dose, up to 75 millicuries 0% 12 $0.00
A9540 Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries 0% 12 $0.00
73090 0% 35 $0.00
J3360 Injection, diazepam, up to 5 mg 0% 52 $0.00
G8987 Self care functional limitation, current status, at therapy episode outset and at reporting intervals 0% 90 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 0% 54 $0.00
51797 0% 12 $0.00
J2560 Injection, phenobarbital sodium, up to 120 mg 0% 17 $0.00
72170 0% 14 $0.00
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg 0% 24 $0.00
C9399 Unclassified drugs or biologicals 0% 110 $0.00
A4364 Adhesive, liquid or equal, any type, per oz 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRICHARDSON, KARA (ASSISTANT TREASURER)
Same official

Other billing entities under RICHARDSON, KARA

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.